➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Mallinckrodt

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Istaroxime

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Istaroxime?

Istaroxime is an investigational drug.

There have been 7 clinical trials for Istaroxime. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2009.

The most common disease conditions in clinical trials are Heart Failure, Shock, Cardiogenic, and Shock. The leading clinical trial sponsors are Lee's Pharmaceutical Limited, CVie Therapeutics Co. Ltd., and Debiopharm International SA.

Recent Clinical Trials for Istaroxime
TitleSponsorPhase
The Safety and Efficacy of Istaroxime for Pre-Cardiogenic ShockMomentum Research, Inc.Phase 2
The Safety and Efficacy of Istaroxime for Pre-Cardiogenic ShockWindtree TherapeuticsPhase 2
The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart FailureCVie Therapeutics Co. Ltd.Phase 2

See all Istaroxime clinical trials

Clinical Trial Summary for Istaroxime

Top disease conditions for Istaroxime
Top clinical trial sponsors for Istaroxime

See all Istaroxime clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.